Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Abortion Surveillance - United States, 2016.

Jatlaoui TC, Eckhaus L, Mandel MG, Nguyen A, Oduyebo T, Petersen E, Whiteman MK.

MMWR Surveill Summ. 2019 Nov 29;68(11):1-41. doi: 10.15585/mmwr.ss6811a1.

PMID:
31774741
2.

Changes in US health care provider attitudes related to contraceptive safety before and after the release of National Guidance.

Zapata LB, Morgan IA, Curtis KM, Folger SG, Whiteman MK.

Contraception. 2019 Nov;100(5):413-419. doi: 10.1016/j.contraception.2019.07.142. Epub 2019 Jul 29.

PMID:
31369735
3.

Healthcare provider knowledge regarding oral contraception effectiveness for women with a history of bariatric malabsorptive procedures.

Shah JP, Jatlaoui TC, Zapata LB, Curtis KM, Pagano HP, Whiteman MK.

Surg Obes Relat Dis. 2019 Aug;15(8):1355-1361. doi: 10.1016/j.soard.2019.06.007. Epub 2019 Jun 17.

4.

Factors associated with postpartum use of long-acting reversible contraception.

Oduyebo T, Zapata LB, Boutot ME, Tepper NK, Curtis KM, D'Angelo DV, Marchbanks PA, Whiteman MK.

Am J Obstet Gynecol. 2019 Jul;221(1):43.e1-43.e11. doi: 10.1016/j.ajog.2019.03.005. Epub 2019 Mar 15.

PMID:
30885772
5.

In Reply.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Curtis KM.

Obstet Gynecol. 2019 Mar;133(3):582-583. doi: 10.1097/AOG.0000000000003145. No abstract available.

PMID:
30801457
6.

Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.

Ermias Y, Morgan IA, Curtis KM, Whiteman MK, Horton LG, Zapata LB.

Contraception. 2019 May;99(5):300-305. doi: 10.1016/j.contraception.2019.01.005. Epub 2019 Feb 11.

PMID:
30763582
7.

Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.

Tepper NK, Jeng G, Curtis KM, Boutot ME, Boulet SL, Whiteman MK.

Obstet Gynecol. 2019 Mar;133(3):533-540. doi: 10.1097/AOG.0000000000003135.

PMID:
30741807
8.

Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.

Morgan IA, Zapata LB, Curtis KM, Whiteman MK.

J Pediatr Adolesc Gynecol. 2019 Aug;32(4):402-408. doi: 10.1016/j.jpag.2019.01.007. Epub 2019 Feb 4.

PMID:
30731216
9.

Abortion Surveillance - United States, 2015.

Jatlaoui TC, Boutot ME, Mandel MG, Whiteman MK, Ti A, Petersen E, Pazol K.

MMWR Surveill Summ. 2018 Nov 23;67(13):1-45. doi: 10.15585/mmwr.ss6713a1.

10.

Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.

Morgan IA, Ermias Y, Zapata LB, Curtis KM, Whiteman MK.

J Adolesc Health. 2019 Feb;64(2):211-218. doi: 10.1016/j.jadohealth.2018.08.012. Epub 2018 Nov 2.

PMID:
30392865
11.

Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ, Marchbanks PA, Curtis KM.

Obstet Gynecol. 2018 Oct;132(4):895-905. doi: 10.1097/AOG.0000000000002822.

12.

Dissemination and use of WHO family planning guidance and tools: a qualitative assessment.

Kraft JM, Oduyebo T, Jatlaoui TC, Curtis KM, Whiteman MK, Zapata LB, Gaffield ME.

Health Res Policy Syst. 2018 May 22;16(1):42. doi: 10.1186/s12961-018-0321-1.

13.

Hormonal Contraceptive Use Among Women of Older Reproductive Age: Considering Risks and Benefits.

Tepper NK, Godfrey EM, Folger SG, Whiteman MK, Marchbanks PA, Curtis KM.

J Womens Health (Larchmt). 2018 Apr;27(4):413-417. doi: 10.1089/jwh.2018.6985. Epub 2018 Mar 19.

PMID:
29634450
14.

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.

Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK.

MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. doi: 10.15585/mmwr.mm6637a6.

15.

Trends in contraceptive use according to HIV status among privately insured women in the United States.

Haddad LB, Monsour M, Tepper NK, Whiteman MK, Kourtis AP, Jamieson DJ.

Am J Obstet Gynecol. 2017 Dec;217(6):676.e1-676.e11. doi: 10.1016/j.ajog.2017.08.006. Epub 2017 Sep 1.

16.

Contraception for women with multiple sclerosis: Guidance for healthcare providers.

Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.

Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24. Review.

17.

Removing barriers to contraception through use of criteria to assess pregnancy risk.

Tepper NK, Curtis KM, Jatlaoui TC, Whiteman MK.

Contraception. 2017 Apr;95(4):323-325. doi: 10.1016/j.contraception.2017.02.002. Epub 2017 Feb 15. No abstract available.

PMID:
28214517
18.

Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.

Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ.

Am J Obstet Gynecol. 2017 May;216(5):489.e1-489.e7. doi: 10.1016/j.ajog.2016.12.019. Epub 2016 Dec 26.

PMID:
28034652
19.

Healthcare Provider Attitudes of Safety of Intrauterine Devices in the Postpartum Period.

Rauh-Benoit LA, Tepper NK, Zapata LB, Whiteman MK, Curtis KM, Mandel MG, Marchbanks PA, Jamieson DJ.

J Womens Health (Larchmt). 2017 Jul;26(7):768-773. doi: 10.1089/jwh.2016.5985. Epub 2016 Dec 19.

PMID:
27992305
20.

Updated Guidance for Safe and Effective Use of Contraception.

Tepper NK, Curtis KM, Jatlaoui TC, Whiteman MK.

J Womens Health (Larchmt). 2016 Nov;25(11):1097-1101.

PMID:
27841957
21.

Removing medical barriers to contraception - evidence-based recommendations from the Centers for Disease Control and Prevention, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, Whiteman MK.

Contraception. 2016 Dec;94(6):579-581. doi: 10.1016/j.contraception.2016.08.007. Epub 2016 Aug 30. No abstract available.

PMID:
27589882
22.

U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK.

MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. doi: 10.15585/mmwr.rr6504a1.

PMID:
27467319
23.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK.

MMWR Recomm Rep. 2016 Jul 29;65(3):1-103. doi: 10.15585/mmwr.rr6503a1.

PMID:
27467196
24.

Contraceptive use among women with multiple sclerosis: a systematic review.

Zapata LB, Oduyebo T, Whiteman MK, Houtchens MK, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):612-620. doi: 10.1016/j.contraception.2016.07.013. Epub 2016 Jul 21. Review.

25.

The safety of intrauterine devices in breastfeeding women: a systematic review.

Berry-Bibee EN, Tepper NK, Jatlaoui TC, Whiteman MK, Jamieson DJ, Curtis KM.

Contraception. 2016 Dec;94(6):725-738. doi: 10.1016/j.contraception.2016.07.006. Epub 2016 Jul 13. Review.

PMID:
27421765
26.

Contraceptive safety among women with cystic fibrosis: a systematic review.

Whiteman MK, Oduyebo T, Zapata LB, Walker S, Curtis KM.

Contraception. 2016 Dec;94(6):621-629. doi: 10.1016/j.contraception.2016.05.016. Epub 2016 Jun 7. Review.

PMID:
27287694
27.

Safety of hormonal contraceptives among women with migraine: A systematic review.

Tepper NK, Whiteman MK, Zapata LB, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):630-640. doi: 10.1016/j.contraception.2016.04.016. Epub 2016 May 3. Review.

PMID:
27153744
28.

Progestin-only contraception and thromboembolism: A systematic review.

Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM.

Contraception. 2016 Dec;94(6):678-700. doi: 10.1016/j.contraception.2016.04.014. Epub 2016 May 3. Review.

PMID:
27153743
29.

Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population.

Champaloux SW, Tepper NK, Curtis KM, Zapata LB, Whiteman MK, Marchbanks PA, Jamieson DJ.

Obstet Gynecol. 2015 Dec;126(6):1151-9. doi: 10.1097/AOG.0000000000001134.

PMID:
26551183
30.

Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.

Whiteman MK, Jeng G, Samarina A, Akatova N, Martirosyan M, Kissin DM, Curtis KM, Marchbanks PA, Hillis SD, Mandel MG, Jamieson DJ.

Contraception. 2016 Jan;93(1):17-24. doi: 10.1016/j.contraception.2015.07.003. Epub 2015 Jul 18.

31.

Use of Dual Methods for Protection from Unintended Pregnancy and Sexually Transmitted Diseases in Adolescent African American Women.

Kottke M, Whiteman MK, Kraft JM, Goedken P, Wiener J, Kourtis AP, DiClemente R.

J Pediatr Adolesc Gynecol. 2015 Dec;28(6):543-8. doi: 10.1016/j.jpag.2015.04.008. Epub 2015 Apr 21.

32.

Identifying psychosocial and social correlates of sexually transmitted diseases among black female teenagers.

Kraft JM, Whiteman MK, Carter MW, Snead MC, DiClemente RJ, Murray CC, Hatfield-Timajchy K, Kottke M.

Sex Transm Dis. 2015 Apr;42(4):192-7. doi: 10.1097/OLQ.0000000000000254.

33.

Sexually transmitted disease partner notification among African-American, adolescent women.

Buchsbaum A, Gallo MF, Whiteman MK, Cwiak C, Goedken P, Kraft JM, Jamieson DJ, Kottke M.

Infect Dis Obstet Gynecol. 2014;2014:619632. doi: 10.1155/2014/619632. Epub 2014 Dec 25.

34.

Sporadic contraceptive use and nonuse: age-specific prevalence and associated factors.

Pazol K, Whiteman MK, Folger SG, Kourtis AP, Marchbanks PA, Jamieson DJ.

Am J Obstet Gynecol. 2015 Mar;212(3):324.e1-8. doi: 10.1016/j.ajog.2014.10.004. Epub 2014 Oct 8.

35.

In reply.

Tepper NK, Boulet SL, Whiteman MK, Monsour M, Marchbanks PA, Hooper WC, Curtis KM.

Obstet Gynecol. 2014 Oct;124(4):838-9. doi: 10.1097/AOG.0000000000000486. No abstract available.

36.

Contraceptive counseling and postpartum contraceptive use.

Zapata LB, Murtaza S, Whiteman MK, Jamieson DJ, Robbins CL, Marchbanks PA, D'Angelo DV, Curtis KM.

Am J Obstet Gynecol. 2015 Feb;212(2):171.e1-8. doi: 10.1016/j.ajog.2014.07.059. Epub 2014 Aug 2.

37.

Postpartum venous thromboembolism: incidence and risk factors.

Tepper NK, Boulet SL, Whiteman MK, Monsour M, Marchbanks PA, Hooper WC, Curtis KM.

Obstet Gynecol. 2014 May;123(5):987-96. doi: 10.1097/AOG.0000000000000230.

PMID:
24785851
38.

Using a checklist to assess pregnancy in teenagers and young women.

Whiteman MK, Tepper NK, Kottke M, Curtis KM, Goedken P, Mandel MG, Marchbanks PA.

Obstet Gynecol. 2014 Apr;123(4):777-84. doi: 10.1097/AOG.0000000000000179.

39.

Dual use of condoms with other contraceptive methods among adolescents and young women in the United States.

Tyler CP, Whiteman MK, Kraft JM, Zapata LB, Hillis SD, Curtis KM, Anderson J, Pazol K, Marchbanks PA.

J Adolesc Health. 2014 Feb;54(2):169-75. doi: 10.1016/j.jadohealth.2013.07.042. Epub 2013 Sep 25.

PMID:
24074606
40.

Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review.

Godfrey EM, Whiteman MK, Curtis KM.

Contraception. 2013 May;87(5):567-75. doi: 10.1016/j.contraception.2012.08.005. Epub 2012 Oct 5. Review.

PMID:
23044386
41.

Pregnancies after hysteroscopic sterilization: a systematic review.

Cleary TP, Tepper NK, Cwiak C, Whiteman MK, Jamieson DJ, Marchbanks PA, Curtis KM.

Contraception. 2013 May;87(5):539-48. doi: 10.1016/j.contraception.2012.08.006. Epub 2012 Oct 4. Review.

PMID:
23040124
42.

Respiratory illness hospitalizations among pregnant women during influenza season, 1998-2008.

Martin A, Cox S, Jamieson DJ, Whiteman MK, Kulkarni A, Tepper NK.

Matern Child Health J. 2013 Sep;17(7):1325-31. doi: 10.1007/s10995-012-1135-3.

43.

When can a woman have an intrauterine device inserted? A systematic review.

Whiteman MK, Tyler CP, Folger SG, Gaffield ME, Curtis KM.

Contraception. 2013 May;87(5):666-73. doi: 10.1016/j.contraception.2012.08.015. Epub 2012 Sep 17. Review.

44.

Complications of common gynecologic surgeries among HIV-infected women in the United States.

Penman-Aguilar A, Whiteman MK, Cox S, Posner SF, Meikle SF, Kourtis AP, Jamieson DJ.

Infect Dis Obstet Gynecol. 2012;2012:610876. doi: 10.1155/2012/610876. Epub 2012 May 17.

45.

The effect of body mass index and weight change on epithelial ovarian cancer survival in younger women: a long-term follow-up study.

Tyler CP, Whiteman MK, Zapata LB, Hillis SD, Curtis KM, McDonald J, Wingo PA, Kulkarni A, Marchbanks PA.

J Womens Health (Larchmt). 2012 Aug;21(8):865-71. doi: 10.1089/jwh.2012.3487. Epub 2012 Jun 4.

PMID:
22663301
46.

Dual protection use to prevent STIs and unintended pregnancy.

Sales JM, Whiteman MK, Kottke MJ, Madden T, DiClemente RJ.

Infect Dis Obstet Gynecol. 2012;2012:972689. doi: 10.1155/2012/972689. Epub 2012 Mar 20. No abstract available.

47.

Health care provider attitudes and practices related to intrauterine devices for nulliparous women.

Tyler CP, Whiteman MK, Zapata LB, Curtis KM, Hillis SD, Marchbanks PA.

Obstet Gynecol. 2012 Apr;119(4):762-71. doi: 10.1097/AOG.0b013e31824aca39.

PMID:
22433340
48.

Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States.

Whiteman MK, Cox S, Tepper NK, Curtis KM, Jamieson DJ, Penman-Aguilar A, Marchbanks PA.

Am J Obstet Gynecol. 2012 Feb;206(2):127.e1-7. doi: 10.1016/j.ajog.2011.08.004. Epub 2011 Aug 11.

PMID:
21963310
49.

Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.

Asante A, Whiteman MK, Kulkarni A, Cox S, Marchbanks PA, Jamieson DJ.

Obstet Gynecol. 2010 Nov;116(5):1088-95. doi: 10.1097/AOG.0b013e3181f5ec9d.

PMID:
20966693
50.

Use of contraceptive methods among women with endometrial hyperplasia: a systematic review.

Whiteman MK, Zapata LB, Tepper NK, Marchbanks PA, Curtis KM.

Contraception. 2010 Jul;82(1):56-63. doi: 10.1016/j.contraception.2010.02.005. Epub 2010 Mar 29. Review.

PMID:
20682143

Supplemental Content

Loading ...
Support Center